Concepedia

Clapton Dias

CD

15

Publications

1.8K

Citations

14

H-Index

2000

Active since

Affiliations

Amgen (United States)(Current)

University of Missouri–Kansas City

BioMarin (United States)

Pfizer (United States)

Gilead Sciences (United States)

Clapton Dias is an author at Amgen (United States) specializing in medicine, pharmacology, and cardiovascular disease.

Top concepts

Publications per year

2000–2019

15

Publications

15

Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

Gail M. Gauvreau, Paul M. O’Byrne, Louis‐Philippe Boulet et al. · New England Journal of Medicine · 2014 · 767 citations · Full text

Effects of AMG 145 on Low-Density Lipoprotein Cholesterol Levels

Clapton Dias, Adam J. Shaywitz, Scott M. Wasserman et al. · Journal of the American College of Cardiology · 2012 · 233 citations

, , +4

Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor<scp>X</scp>a inhibitor

Charles Frost, Wonkyung Byon, Yan Song et al. · British Journal of Clinical Pharmacology · 2014 · 158 citations · Full text

Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Rivaroxaban in Chronic Hemodialysis

Clapton Dias, Kenneth Todd Moore, Joe Murphy et al. · American Journal of Nephrology · 2016 · 129 citations · Full text

Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa

Blisse Vakkalagadda, Charles Frost, Wonkyung Byon et al. · American Journal of Cardiovascular Drugs · 2016 · 116 citations

, , +5

Rows per page

1–5 of 15